62
Views
4
CrossRef citations to date
0
Altmetric
Review

Medication adherence in the management of nocturia: challenges and solutions

, , &
Pages 77-85 | Published online: 13 Jan 2015

References

  • OsmanNIChappleCRWeinAJNocturia: current concepts and future perspectivesActa Physiol (Oxf)2013207536523033860
  • AbramsPCardozoLFallMThe standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence SocietyNeurourol Urodyn20022116717811857671
  • WeissJPBlaivasJGBliwiseDLThe evaluation and treatment of nocturia: a consensus statementBJU Int201110862121676145
  • WeissJPBlaivasJGBlankerMHThe New England Research Institutes, Inc. (NERI) Nocturia Advisory Conference 2012: focus on outcomes of therapyBJU Int201311170071623360086
  • BoschJLWeissJPThe prevalence and causes of nocturiaJ Urol2012189S86S9223234639
  • van DoornBBoschJLNocturia in older menMaturitas20127181222079871
  • GoessaertASDenysMADeryckereSEveraertKNocturnal polyuria in a nursing home and effect on quality of lifeJ Am Geriatr Soc2013611812181324117293
  • MarklandADVaughanCPJohnsonTM2ndGoodePSReddenDTBurgioKLPrevalence of nocturia in United States men: results from the National Health and Nutritional Examination SurveyJ Urol2011185998100221251675
  • van KerrebroeckPAbramsPChaikinDThe standardization of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence SocietyNeurourol Urodyn20022117918311857672
  • KerrebroeckPVAnderssonKETerminology, epidemiology, etiology, and pathophysiology of nocturiaNeurourol Urodyn201433S2S524729150
  • BennerJSNicholMBRovnerESPatient-reported reasons for discontinuing overactive bladder medicationBJU Int20101051276128219912188
  • KobeltGBorgströmFMattiassonAProductivity, vitality and utility in a group of healthy professionally active individuals with nocturiaBJU Int20039119019412581002
  • LoseGLalosOFreemanRMvan KerrebroeckPEfficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in womenAm J Obstet Gynecol20031891106111314586363
  • WeissJPWeinAJvan KerrebroeckPNocturia: new directionsNeurourol Urodyn20113070070321661016
  • BliwiseDLRosenRCBauNImpact of nocturia on sleep and quality of life: a brief, selected review for the International Consultation on Incontinence Research Society (ICI-RS) nocturia think tankNeurourol Urodyn201433S15S1824729148
  • CarotenutoMEspositoMPascottoAMigraine and enuresis in children: an unusual correlation?Med Hypotheses20107512012220185246
  • CarotenutoMEspositoMPascottoAFacial patterns and primary nocturnal enuresis in childrenSleep Breath20111522122720607423
  • EspositoMCarotenutoMRoccellaMPrimary nocturnal enuresis and learning disabilityMinerva Pediatr2011639910421487372
  • EspositoMGallaiBParisiLPrimary nocturnal enuresis as a risk factor for sleep disorders: an observational questionnaire-based multicenter studyNeuropsychiatr Dis Treat2013943744323579788
  • EspositoMGallaiBParisiLVisuomotor competencies and primary monosymptomatic nocturnal enuresis in prepubertal aged childrenNeuropsychiatr Dis Treat2013992192923847418
  • CornuJNAbramsPChappleCRA contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management – a systematic review and meta analysisEur Urol20126287789022840350
  • JohnsonTM2ndBurgioKLReddenDTWrightKCGoodePSEffects of behavioral and drug therapy on nocturia in older incontinent womenJ Am Geriatr Soc20055384685015877562
  • JohnsonTM2ndMarklandADGoodePSEfficacy of adding behavioural treatment or antimuscarinic drug therapy to α-blocker therapy in men with nocturiaBJU Int201311210010823448285
  • JohnsonTM2ndJonesKWillifordWOKutnerMHIssaMMLeporHChanges in nocturia from medical treatment of BPH. Secondary analysis of the VA Cooperative Study TrialJ Urol2003170140148
  • MattiassonAAbramsPVan KerrebroeckPWalterSWeissJEfficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in menBJU Int20028985586212010228
  • OsterbergLBlaschkeTAdherence to medicationN Engl J Med200535348749716079372
  • D’SouzaAOSmithMJMillerLADoyleJArielyRPersistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care planJ Manag Care Pharm20081429130118439051
  • EasterlingSAMasterVCarneyKJEvaluation and management of patients with nocturiaJAAPA201427364224463749
  • YuYFNicholMBYuAPAhnJPersistence and adherence of medications for chronic overactive bladder/urinary incontinence in the California Medicaid programValue Health2005849550516091027
  • PelletierEMVatsVClemensMJPharmacotherapy adherence and costs versus nonpharmacologic management in overactive bladderAm J Manag Care200915S108S11419355799
  • RosenRCHolm-LarsenTKupelianVWeinAJConsequences of nocturiaPostgrad Med2013125384623841962
  • SearsCLLewisCNoelKAlbrightTSFischerJROveractive bladder medication adherence when medication is free to patientsJ Urol20101831077108120092838
  • TikkinenKAAuvinenAJohnsonTM2ndA systematic evaluation of factors associated with nocturia – the population based FINNO studyAm J Epidemiol200917036136819515794
  • VeenboerPWBoschJLLong-term adherence to antimuscarinic therapy in everyday practice: a systematic reviewJ Urol20101911003100824140548
  • Van HerzeeleCAlovaIEvansJPoor compliance with primary nocturnal enuresis therapy may contribute to insufficient desmopressin responseJ Urol20091822045204919695639
  • GourovaLWvan de BeekCSpigtMGNiemanFHvan KerrebroeckPEPredictive factors for nocturia in elderly men: a cross sectional study in 21 general practicesBJU Int20069752853216469020
  • Institute of Medicine of the National AcademiesCrossing the Quality Chasm: A New Health System for the 21st CenturyWashingtonNational Academies2001
  • AndersenRMRevisiting behavioral model and access to medical care: does it matter?J Health Soc Behav1995361107738325
  • AdayLAAndersenRA framework for the study of access to medical careHealth Serv Res197492082204436074
  • MurrayMDMorrowDGWeinerMA conceptual framework to study medication adherence in older adultsAm J Geriatr Pharmacother20042364315555477
  • BasraRKWaggAChappleCA review of adherence to drug therapy in patients with overactive bladderBJU Int200810277477918616691
  • YeawJBennerJSWaltJGSianSSmithDBComparing adherence and persistence across 6 chronic medication classesJ Manag Care Pharm20091572874019954264
  • Vecchioli ScaldazzaCMorosettiCPaceGAziziBGiannubiloWFerraraVHas the cost of anti-muscarinic a key role in the success rate of patients diagnosed with overactive bladder syndrome?Arch Ital Urol Androl201284687322908774
  • BrubakerLFanningKGoldbergELPredictors of discontinuing overactive bladder medicationsBJU Int20101051283129019912189
  • GambleTSandPPatient perspectives in the management of overactive bladder, focus on transdermal oxybutyninPatient Prefer Adherence2008234935619920982
  • ShayaFTBlumeSGuAZyczynskiTJumadilovaZPersistence with overactive bladder pharmacotherapy in a Medicaid populationAm J Manag Care200511S121S12916161385
  • RobinsonJHCallisterLCBerryJADearingKAPatient-centered care and adherence: definitions and applications to improve outcomesJ Am Acad Nurse Pract20082060060719120591
  • MeadNBowerPPatient-centeredness: a conceptual framework and review of the empirical literatureSoc Sci Med2000511087111011005395
  • HofmeesterIKollenBJSteffensMGThe association between nocturia and nocturnal polyuria in clinical and epidemiological studies: a systematic review and meta analysesJ Urol20131911028103324184367
  • RaheemOAOroscoRKDavidsonTMLakinCClinical predictors of nocturia in the sleep apnea populationUrol Ann20146313524669119
  • SongMHongBSChunJYHanJYChooMSSafety and efficacy of desmopressin for the treatment of nocturia in elderly patients: a cohort studyInt Urol Nephrol2014461495149924595604
  • TikkinenKAJohnsonTM2ndTammelaTLNocturia frequency, bother, and quality of life: how often is too often? A population-based study in FinlandEur Urol20105748849819361907
  • YokoyamaOHiroSHottaSMogamiSYamagamiHEfficacy of fesoterodine on nocturia and quality of sleep in Asian patients with overactive bladderUrology20148375075524518285
  • AdayLAAndersenRA framework for the study of access to medical careHealth Serv Res197492082204436074
  • BalkrishnanRBhosleMJCamachoFTAndersonRTPredictors of medication adherence and associated health care costs in an older population with overactive bladder syndrome: a longitudinal cohort studyJ Urol20061751067107216469620
  • BreyerBNShindelAWEricksonBABlaschkoSDSteersWDRosenRCThe association of depression, anxiety and nocturia: a systematic reviewJ Urol201319095395723680309
  • ChancellorMBMigliaccio-WalleKBramleyTJChaudhariSLCorbellCGlobeDLong-term patterns of use and treatment failure with anticholinergic agents for overactive bladderClin Ther2013351744175124091072
  • ChungMSChuangYCLeeJJLeeWCChancellorMBLiuRTPrevalence and associated risk factors of nocturia and subsequent mortality in 1,301 patients with type 2 diabetesInt Urol Nephrol2014461269127524595602
  • YoshimuraKOharaHIchiokaKNocturia and benign prostatic hyperplasiaUrology20036178679012670566
  • JohnsonTM2ndBurrowsPKKusekJWThe effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasiaJ Urol20071782045205017869295
  • WeissJPWeinAJVan KerrebroeckPFuture research guidance for nocturiaNeurourol Urodyn201433Suppl 1S2524375762
  • RackleyRWeissJPRovnerESWangJTGuanZNighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturiaUrology20066773173616618562
  • BrubakerLFitzGeraldMPNocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptomsInt Urogynecol J Pelvic Floor Dysfunct20071873774117131169
  • HirstGRWatkinsAJGuerreroKBotulinum toxin B is not an effective treatment of refractory overactive bladderUrology200769697317270619
  • SchmidDMSauermannPWernerMExperience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergicsJournal of Urology200617617718516753396
  • ApostolidisADasguptaPDenysPRecommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus reportEur Urol20095510012018823697
  • DuthieJBVincentMHerbisonGPWilsonDIWilsonDBotulinum toxin injections for adults with overactive bladder syndromeCochrane Database Syst Rev201112CD00549322161392
  • WeissJPJuulKVWeinAJManagement of nocturia: the role of antidiuretic pharmacotherapyNeurourol Urodyn201433S19S2424729149
  • ChenFYDaiYTLiuCKYuHJLiuCYChenTHPerception of nocturia and medical consulting behavior among community-dwelling womenInt Urogynecol J Pelvic Floor Dysfunct20071843143616874440
  • SextonCCNotteSMMaroulisCPersistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literatureInt J Clin Pract20116556758521489081
  • GulurDMMevchaAMDrakeMJNocturia as a manifestation of systemic diseaseBJU Int201010770271321355977
  • NevéusTLeissnerLRudbladSBazarganiFOrthodontic widening of the palate may provide a cure for selected children with therapy-resistant enuresisActa Paediatr201410311871191
  • van KerrebroeckPNocturia: current status and future perspectivesCurr Opin Obstet Gynecol20112337638521897234
  • WaggACompionGFaheyASiddiquiEPersistence with prescribed antimuscarinic therapy for overactive bladder: a UK experienceBJU Int20121101767177422409769
  • EisenhardtASchneiderTCruzFOelkeMConsistent and significant improvement of nighttime voiding frequency (nocturia) with silodosin in men with LUTS suggestive of BPH: pooled analysis of three randomized, placebo-controlled, double-blind phase III studiesWorld J Urol2014321119112524442560
  • AsplundRPharmacotherapy for nocturia in the elderly patientDrugs Aging20072432534317432926
  • NevéusTLeissnerLRudbladSBazarganiFRespiration during sleep in children with therapy-resistant enuresisActa Paediatr201410330030424236639
  • CederbladMSarkadiAEngvallGNevéusTInfrequent enuresis, the uninvestigated majority comparisons between children with enuresis of varying severityJ Pediatr Urol Epub ahead of print2014
  • GomelskyADmochowskiRRUpdate on the management of overactive bladder: patient considerations and adherenceOpen Access J Urol2010371724198630
  • JohnstonSJanningSWHaasGPComparative persistence and adherence to overactive bladder medications in patients with and without diabetesInt J Clin Pract2012661042105123067028
  • HaaFCastro-DiazDPersistence with antimuscarinic therapy in patients with overactive bladderInt J Clin Pract20055993193716033615
  • HampelCLong-term management of overactive bladder with anti-muscarinic agentsEur Urol Suppl20076432437
  • MobleyDFBaumNEtiology, evaluation, and management of nocturia in elderly men and womenPostgrad Med201412614715324685979
  • JundtKSchreyerKFrieseKPeschersUAnticholinergic therapy: do the patients take the pills prescribed?Arch Gynecol Obstet201128466366621046135
  • FilipettoFAFuldaKGHolthusenAEMcKeithenTMMcFaddenPThe patient perspective on overactive bladder: a mixed methods needs assessmentBMC Fam Pract2014159624885491
  • MausethSASkurtveitSSpigsetOAdherence, persistence and switch rates for anticholinergic drugs used for overactive bladder in women: data from the Norwegian Prescription DatabaseActa Obstet Gynecol Scand2013921208121523763552